Hematology: Leveraging the Power of the CBC

In this video, Dr. Serrando discusses the streamlined workflow technology and state-of-the-art pathology-screening capabilities of the DxH 900 Hematology analyzer and how her laboratory applies these data to flag abnormal cells and identify disease. She discusses how test results provide clinically significant data and reviews the CBC-Diff results from a patient with AML. Explore how the innovative technology of the DxH 900 is used to evaluate and examine different hematological clinical cases. View DxH 900 Casebook today at: https://www.beckmancoulter.com/DxH900